Aclarion IncNASDAQ:ACONNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.1758
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1750/ 3
- Ask / Lots0.1941/ 1
- Open / Previous Close--- / 0.1758
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACON |
|---|---|---|
| 09:32 ET | 8460 | 0.1799 |
| 09:35 ET | 2100 | 0.18 |
| 09:37 ET | 2755 | 0.18 |
| 09:44 ET | 3203 | 0.1813 |
| 09:46 ET | 6300 | 0.1809 |
| 09:48 ET | 1000 | 0.180662 |
| 09:57 ET | 200 | 0.1809 |
| 10:22 ET | 290 | 0.1796 |
| 10:24 ET | 656 | 0.1796 |
| 10:33 ET | 3000 | 0.179 |
| 11:05 ET | 9439 | 0.176 |
| 11:16 ET | 3003 | 0.175827 |
| 11:21 ET | 500 | 0.1751 |
| 11:48 ET | 2900 | 0.1789 |
| 11:52 ET | 134 | 0.176 |
| 11:59 ET | 1050 | 0.1762 |
| 12:42 ET | 155 | 0.1763 |
| 12:46 ET | 111 | 0.1789 |
| 12:51 ET | 500 | 0.1762 |
| 01:56 ET | 565 | 0.1762 |
| 02:02 ET | 2146 | 0.179 |
| 02:05 ET | 100 | 0.1784 |
| 02:16 ET | 1340 | 0.1788 |
| 02:18 ET | 631 | 0.176273 |
| 02:38 ET | 200 | 0.1785 |
| 02:48 ET | 1000 | 0.177949 |
| 03:03 ET | 1000 | 0.177851 |
| 03:12 ET | 1006 | 0.179 |
| 03:14 ET | 500 | 0.1789 |
| 03:28 ET | 9065 | 0.1788 |
| 03:32 ET | 300 | 0.1789 |
| 03:33 ET | 300 | 0.178 |
| 03:39 ET | 2941 | 0.178 |
| 03:44 ET | 100 | 0.178 |
| 03:46 ET | 25326 | 0.1805 |
| 03:48 ET | 13650 | 0.1779 |
| 03:51 ET | 300 | 0.178 |
| 03:57 ET | 1944 | 0.1781 |
| 04:00 ET | 8163 | 0.1758 |
Nov 21, 2024
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash, from 8:00AM ET on Thursday Nov 21, 2024 by Dow Jones
8:00AM ET on Thursday Nov 21, 2024 by Dow Jones
Nov 14, 2024
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st, from 5:02PM ET on Thursday Nov 14, 2024 by Dow Jones
5:02PM ET on Thursday Nov 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Aclarion Inc | 1.8M | 0.0x | --- |
Allarity Therapeutics Inc | 1.8M | 0.0x | --- |
Panbela Therapeutics Inc | 1.7M | 0.0x | --- |
Salarius Pharmaceuticals Inc | 2.0M | -0.2x | --- |
Dermata Therapeutics Inc | 1.7M | -0.1x | --- |
Bluejay Diagnostics Inc | 1.9M | 0.0x | --- |
Company Information
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
Contact Information
- Headquarters
- 8181 Arista Place, Ste 100BROOMFIELD, CO, United States 80021
- Phone
- 650-241-1740
- Fax
- 302-636-5454
Executives
- Executive Chairman of the Board
- Jeff Thramann
- President, Chief Executive Officer, Director
- Brent Ness
- Chief Financial Officer
- John Lorbiecki
- Chief Strategy Officer
- Ryan Bond
- Lead Independent Director
- William Wesemann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8M |
|---|---|
Revenue (TTM) | $54.0K |
Shares Outstanding | 10.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-4.74 |
Book Value | $-0.88 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 34.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -10,895.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
